About AngioDynamics, Inc. 
AngioDynamics, Inc.
Pharmaceuticals & Biotechnology
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.
Company Coordinates 
Company Details
14 Plaza Dr , LATHAM NY : 12110-2166
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 53 Schemes (46.45%)
Foreign Institutions
Held by 82 Foreign Institutions (14.61%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Howard Donnelly
Independent Chairman of the Board
Mr. James Clemmer
President, Chief Executive Officer, Director
Ms. Eileen Auen
Independent Director
Mr. Wesley Johnson
Independent Director
Ms. Karen Licitra
Independent Director
Mr. Dennis Meteny
Independent Director
Ms. Jan Reed
Independent Director
Revenue and Profits:
Net Sales:
80 Million
(Quarterly Results - May 2025)
Net Profit:
-6 Million
Pharmaceuticals & Biotechnology
USD 447 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.30
-9.89%
2.44






